Ethical guidelines for clinical research related to public health emergencies.
突发公共卫生事件临床研究伦理指南.
clinical research
ethical guidelines
public health emergency
Journal
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
ISSN: 1672-7347
Titre abrégé: Zhong Nan Da Xue Xue Bao Yi Xue Ban
Pays: China
ID NLM: 101230586
Informations de publication
Date de publication:
28 Aug 2020
28 Aug 2020
Historique:
entrez:
14
10
2020
pubmed:
15
10
2020
medline:
21
10
2020
Statut:
ppublish
Résumé
Clinical research is an important part in responding to public health emergencies, reducing epidemic hazards, and protecting public health and life safety. However, different from the general clinical research, there are many uncertainties and knowledge gaps in the clinical research of public health emergencies, and there is no unified standard for the clinical research ethics of public health emergencies in the world, which poses a new challenge to the practice of ethical research in China. In this article, we will combine with the ethical experience of clinical research on public health emergencies in China, propose the ethical guidelines for clinical research related to public health emergencies, including fast and efficient ethical review mechanism, scientific and reasonable research design, a reasonable balance of risk and benefit, adhere to the fundamental value of bioethics, to ensure that fully informed consent, to protect the subject's privacy, and recruiting fairly and reasonably. Further emphasized the prioritizing of public health and clinical emergency treatment, that is, under the situation of outbreak, all kinds of relevant public health clinical research can't affect the priority of epidemic prevention and control and clinical supportive treatment measures. 临床研究是应对突发公共卫生事件,降低疫情危害,保护公众健康和生命安全的重要环节。然而,不同于一般情况下的临床研究,突发公共卫生事件临床研究存在诸多不确定性和知识缺口,全球关于突发公共卫生事件临床研究伦理尚无统一标准,这对我国伦理研究实践提出了新的挑战。本文结合我国突发公共卫生事件临床研究伦理经验,提出突发公共卫生事件临床研究伦理指南应包括快速高效的伦理审查机制,科学合理的研究方案,风险与受益的合理权衡,坚持生命伦理的基本价值,确保充分知情同意,保护受试者个人隐私,以及公正合理地招募受试者等内容,进一步强调了保证公共卫生和临床应急处理的优先性,即在疫情暴发的情境下,各类公共卫生事件临床研究不能影响疫情防控和临床支持性治疗措施的优先性。.
Autres résumés
Type: Publisher
(chi)
临床研究是应对突发公共卫生事件,降低疫情危害,保护公众健康和生命安全的重要环节。然而,不同于一般情况下的临床研究,突发公共卫生事件临床研究存在诸多不确定性和知识缺口,全球关于突发公共卫生事件临床研究伦理尚无统一标准,这对我国伦理研究实践提出了新的挑战。本文结合我国突发公共卫生事件临床研究伦理经验,提出突发公共卫生事件临床研究伦理指南应包括快速高效的伦理审查机制,科学合理的研究方案,风险与受益的合理权衡,坚持生命伦理的基本价值,确保充分知情同意,保护受试者个人隐私,以及公正合理地招募受试者等内容,进一步强调了保证公共卫生和临床应急处理的优先性,即在疫情暴发的情境下,各类公共卫生事件临床研究不能影响疫情防控和临床支持性治疗措施的优先性。.
Identifiants
pubmed: 33053527
pii: 1672-7347(2020)08-0881-05
doi: 10.11817/j.issn.1672-7347.2020.200317
pii:
doi:
Types de publication
Journal Article
Langues
eng
chi
Sous-ensembles de citation
IM
Pagination
881-885Subventions
Organisme : Novel Coronavirus Pneumonia Prevention and Control First Emergency Project of Central South University, China
ID : 160260007
Références
Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern[J]. Lancet, 2020, 395(10223): 470- 473.
WHO. Statement on the second meeting of the International Health Regulations (2005)[EB/OL]. (2020-01-30)[ 2020-02-26]. https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)- emergency-committee-regarding-the-outbreak-of-novel-coronavirus- (2019-ncov).
WHO. WHO characterizes COVID-19 as a pandemic[EB/OL].(2020-03-11)[ 2020-03-12]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
Nuffield Council on Bioethics. Research in global health emergencies: Ethical issues[EB/OL].(2020-01-28)[ 2020-02-10]. https://www.nuffieldbioethics.org/publications/research-in-global- health-emergencie.
WHO. Guidance for managing ethical issues in infectious disease outbreak. (2016-01-03)[ 2020-02-18]. https://www.who.int/publications-detail/guidance-for-managing-ethical-issues-in-infectious-disease-outbreaks.
中华人民共和国中央政府. 国家突发公共卫生事件应急预案[EB/OL]. (2006-02-28). http://www.gov.cn/gzdt/2006-02/28/content_213129.htm.
Derrick A. Addressing the challenge for expedient ethical review of research in disasters and disease outbreaks[J]. Bioethics, 2019, 33(3): 345.
国家食品药品监督管理总局. 药物临床试验质量管理规范[EB/OL]. (2003-08-06). http://www.nmpa.gov.cn/WS04/CL 2077/300595.html.
国家卫生健康委员会法规司. 涉及人的生物医学研究伦理审查办法[EB/OL]. (2018-08-31). http://www.nhc.gov.cn/fzs/s3576/201808/14ee8ab2388440c4a44ecce0f24e064c.shtml.
International Council for Harmonization of Technical Requirement for Pharmaceuticals for Human Use (ICH), Integrated addendum to ICH E 6(R 1): Guideline for good clinical practice E 6(R 2)[EB/OL]. (2016-11-09). https://www.ich.org.
Abha S. Ethics preparedness: facilitating ethics review during outbreaks-recommendations from an expert panel[J]. BMC Med Ethics, 2019, 20(1): 7- 8.
世界卫生组织. 传染病暴发伦理问题管理指南[M]. 世界中医药学会联合会伦理审查委员会译. 北京: 中国中医药出版社, 2020.
WHO. Standards and operational guidance for ethics review of health-related research with human participants[EB/OL]. (2011-01-09). https://www.who.int/ethics/publications/9789241502 948/en/.
中华人民共和国国务院. 中华人民共和国人类遗传资源管理条例[EB/OL]. (2019-05-28). http://www.gov.cn/zhengce/content/2019-06/10/content_5398829.htm.
中华人民共和国科学技术部. 国务院应对新冠肺炎疫情联防联控机制科研攻关组印发《关于规范医疗机构开展新型冠状病毒肺炎药物治疗临床研究的通知》[EB/OL]. (2020-02-25). http://www.nhc.gov.cn/qjjys/s7949s/202002/01506aeeb2cd4cf698267d2f39b271f8.shtml.